Mary E. Norton

14.1k total citations · 2 hit papers
259 papers, 7.3k citations indexed

About

Mary E. Norton is a scholar working on Pediatrics, Perinatology and Child Health, Obstetrics and Gynecology and Surgery. According to data from OpenAlex, Mary E. Norton has authored 259 papers receiving a total of 7.3k indexed citations (citations by other indexed papers that have themselves been cited), including 184 papers in Pediatrics, Perinatology and Child Health, 46 papers in Obstetrics and Gynecology and 44 papers in Surgery. Recurrent topics in Mary E. Norton's work include Prenatal Screening and Diagnostics (140 papers), Fetal and Pediatric Neurological Disorders (58 papers) and Parvovirus B19 Infection Studies (43 papers). Mary E. Norton is often cited by papers focused on Prenatal Screening and Diagnostics (140 papers), Fetal and Pediatric Neurological Disorders (58 papers) and Parvovirus B19 Infection Studies (43 papers). Mary E. Norton collaborates with scholars based in United States, United Kingdom and Canada. Mary E. Norton's co-authors include Aaron B. Caughey, Jeffrey A. Kuller, Laura L. Jelliffe‐Pawlowski, Rebecca J. Baer, Ronald J. Wapner, Miriam Kuppermann, Robert J. Currier, Herb Brar, Louise C. Laurent and Shilpa Chetty and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Mary E. Norton

244 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cell-free DNA Analysis for Noninvasive Examination of Trisomy

2015 549 citations Mary E. Norton, Bo Jacobsson et al. profile →
Non-Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18

2012 424 citations Mary E. Norton, Herb Brar et al. American Journal of Obstetrics and Gynecology profile →

Peers

Countries citing papers authored by Mary E. Norton

Since Specialization

Citations

This map shows the geographic impact of Mary E. Norton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary E. Norton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary E. Norton more than expected).

Fields of papers citing papers by Mary E. Norton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mary E. Norton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary E. Norton. The network helps show where Mary E. Norton may publish in the future.

Co-authorship network of co-authors of Mary E. Norton

This figure shows the co-authorship network connecting the top 25 collaborators of Mary E. Norton. A scholar is included among the top collaborators of Mary E. Norton based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary E. Norton. Mary E. Norton is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fetal MRI Findings, Etiology, and Outcome in Prenatally Diagnosed Schizencephaly 2024 ·American Journal of Neuroradiology ·Elizabeth George, Rachel Vassar, (unknown), Mary E. Norton, Dawn Gano, Orit A. Glenn	1
2	Trends in Reporting of Nuchal Translucency Measurements After the Clinical Introduction of Cell-Free DNA Screening 2024 ·Obstetrics and Gynecology ·Timothy Wen, Loralei L. Thornburg, Mary E. Norton, Lawrence D. Platt, Lorraine Dugoff, Ashley Hesson, Jean Lea Spitz, (unknown), Bryann Bromley	2
3	Fetal Intraparenchymal Hemorrhage Imaging Patterns, Etiology, and Outcomes: A Single Center Cohort Study 2024 ·Annals of Neurology ·Rachel Vassar, Elizabeth George, (unknown), Yi Li, Mary E. Norton, Orit A. Glenn, Dawn Gano	3
4	Obstetrical, Perinatal, and Genetic Outcomes Associated With Nonreportable Prenatal Cell-Free DNA Screening Results 2024 ·Obstetrical & Gynecological Survey ·Mary E. Norton, Cora MacPherson, Zachary Demko, (unknown), Fergal D. Malone, Ronald J. Wapner, Ashley S. Roman, Asma Khalil, (unknown), Rajeevi Madankumar, (unknown), Sina Haeri, Robert Silver, Nidhi Vohra, Jon Hyett, Kimberly D. Martin, Matthew Rabinowitz, Bo Jacobsson, P. Dar	0
5	Fetal Intracranial Hemorrhage due to Uniparental Disomy and Unmasked MPL‐Related Congenital Amegakaryocytic Thrombocytopenia 2024 ·Prenatal Diagnosis ·Dawn Gano, Orit A. Glenn, Larry Rand, (unknown), Patrick J. Devine, Mary E. Norton, Teresa N. Sparks	1
6	Deep phenotyping expands our knowledge of fetal manifestations of genetic disease 2023 ·American Journal of Obstetrics and Gynecology ·Teresa N. Sparks, Billie R. Lianoglou, (unknown), Kate Swanson, (unknown), Anne Slavotinek, Patrick J. Devine, Uğur Hodoğlugil, Jessica Van Ziffle, Mary E. Norton	2
7	The utility of gene sequencing in identifying an underlying genetic disorder in prenatally suspected lower urinary tract obstruction 2023 ·Prenatal Diagnosis ·(unknown), Karin J. Blakemore, (unknown), Jena L. Miller, (unknown), Hanan E. Shamseldin, Sateesh Maddirevula, Thomas Hays, Billie R. Lianoglou, (unknown), Linda A. Baker, Teresa N. Sparks, Ronald J. Wapner, Fowzan S. Alkuraya, Mary E. Norton, Angie C. Jelin	5
8	High fetal fraction on cell-free fetal DNA screening: is it associated with adverse perinatal outcomes? 2023 ·American Journal of Obstetrics and Gynecology ·Sina Haeri, Mary E. Norton, Bo Jacobsson, Cora MacPherson, (unknown), Zachary Demko, (unknown), P. Dar	0
9	Curriculum and Competency Assessment Program for Training Maternal‐Fetal Medicine Fellows in the Performance of the Detailed Obstetric Ultrasound Examination 2022 ·Journal of Ultrasound in Medicine ·Joanne Stone, Reem Abu-Rustum, Bryann Bromley, Karin Fuchs, (unknown), (unknown), (unknown), Jodi S. Dashe, Wesley Lee, Lawrence D. Platt, (unknown), Mary E. Norton, Beryl R. Benacerraf, Alfred Abuhamad	4
10	Exome sequencing of fetuses with congenital diaphragmatic hernia supports a causal role for NR2F2, PTPN11, and WT1 variants 2021 ·The American Journal of Surgery ·(unknown), Shan Dong, Billie R. Lianoglou, (unknown), Grace Schwartz, Mary E. Norton, Tippi C. MacKenzie, Stephan Sanders	6
11	Environmental and Socioeconomic Factors Influence the Live‐Born Incidence of Congenital Heart Disease: A Population‐Based Study in California 2020 ·Journal of the American Heart Association ·Shabnam Peyvandi, Rebecca J. Baer, Christina Chambers, Mary E. Norton, Satish Rajagopal, Kelli K. Ryckman, Anita J. Moon‐Grady, Laura L. Jelliffe‐Pawlowski, Martina A. Steurer	54
12	Etiology and management of early pregnancy renal anhydramnios: Is there a place for serial amnioinfusions? 2020 ·Prenatal Diagnosis ·Angie C. Jelin, (unknown), (unknown), (unknown), Mary E. Norton, Eric B. Jelin	13
13	Laboratory screening and diagnosis of open neural tube defects, 2019 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG) 2019 ·Genetics in Medicine ·Glenn E. Palomaki, Caleb Bupp, Anthony R. Gregg, Mary E. Norton, Devin Oglesbee, Robert G. Best	18
14	Fetal Treatment 2017: The Evolution of Fetal Therapy Centers - A Joint Opinion from the International Fetal Medicine and Surgical Society (IFMSS) and the North American Fetal Therapy Network (NAFTNet) 2017 ·Fetal Diagnosis and Therapy ·Anita J. Moon‐Grady, Ahmet Baschat, Darrell L. Cass, Mahesh Choolani, Joshua A. Copel, Timothy M. Crombleholme, Jan Deprest, Stephen P. Emery, Mark I. Evans, François I. Luks, Mary E. Norton, Greg Ryan, KuoJen Tsao, Ross Welch, Michael R. Harrison	52
15	The association of maternal lymphatic markers and critical congenital heart defects in the fetus—A population based case‐control study 2017 ·American Journal of Medical Genetics Part A ·Martina A. Steurer, Mary E. Norton, Rebecca J. Baer, Gary M. Shaw, Sheila M. Keating, Anita J. Moon‐Grady, Christina Chambers, Laura L. Jelliffe‐Pawlowski	3
16	Testing for Noonan syndrome after increased nuchal translucency 2017 ·Prenatal Diagnosis ·(unknown), Stephen T. Chasen, Mary E. Norton	27
17	Placental Alpha Microglobulin-1 Compared With Fetal Fibronectin to Predict Preterm Delivery in Symptomatic Women 2017 ·Obstetrics and Gynecology ·Deborah A. Wing, Sina Haeri, (unknown), (unknown), Carl P. Weiner, (unknown), Albert Franco, (unknown), John D. Yeast, (unknown), J. Gerald Quirk, Aisling Murphy, Louise C. Laurent, Nancy T. Field, Mary E. Norton	33
18	Epidemiology of Live Born Infants with Nonimmune Hydrops Fetalis—Insights from a Population-Based Dataset 2017 ·The Journal of Pediatrics ·Martina A. Steurer, Shabnam Peyvandi, Rebecca J. Baer, Tippi C. MacKenzie, (unknown), Mary E. Norton, Laura L. Jelliffe‐Pawlowski, Anita J. Moon‐Grady	27
19	Cell-Free DNA Analysis for Noninvasive Examination of Trisomy 2015 ·Obstetrical & Gynecological Survey ·Mary E. Norton, Bo Jacobsson, Geeta K. Swamy, Louise C. Laurent, Angela C. Ranzini, Herb Brar, Mark W. Tomlinson, Leonardo Pereira, Jean Lea Spitz, Desiree Hollemon, Howard Cuckle, Thomas J. Musci, Ronald J. Wapner	16
20	‘Prenatal Testing and Screening – New Frontiers, New Challenges’ 2005 ·Gynecologic and Obstetric Investigation ·Jeffrey A. Kuller, Mary E. Norton	0

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact